52 related articles for article (PubMed ID: 17539025)
1. Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy.
Yeo W; Mo FK; Chan SL; Leung NW; Hui P; Lam WY; Mok TS; Lam KC; Ho WM; Koh J; Tang JW; Chan AT; Chan PK
Hepatology; 2007 Jun; 45(6):1382-9. PubMed ID: 17539025
[TBL] [Abstract][Full Text] [Related]
2. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.
Zhang YQ; Guo JS
World J Gastroenterol; 2015 Apr; 21(13):3860-6. PubMed ID: 25852270
[TBL] [Abstract][Full Text] [Related]
3. Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma.
Wang P; Wang X; Liu X; Yan F; Yan H; Zhou D; Yu L; Wang X; Yang Z
BMC Cancer; 2023 Jun; 23(1):564. PubMed ID: 37340357
[TBL] [Abstract][Full Text] [Related]
4. HBV viral load and tumor and non-tumor factors in patients with HBV-associated HCC.
Ataman E; Harputluoglu M; Carr BI; Gozukara H; Ince V; Yilmaz S
Hepatol Forum; 2024; 5(2):73-76. PubMed ID: 38487738
[TBL] [Abstract][Full Text] [Related]
5. Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy.
Pan S; Yu Y; Wang S; Tu B; Shen Y; Qiu Q; Liu X; Su N; Zuo Y; Luan J; Zhang JY; Shi M; Meng F; Wang FS
Front Immunol; 2022; 13():892618. PubMed ID: 35711409
[TBL] [Abstract][Full Text] [Related]
6. Association of Virological Response to Antiviral Therapy With Survival in Intermediate-Stage Hepatitis B Virus-Related Hepatocellular Carcinoma After Chemoembolization.
Jin M; Chen Y; Hu S; Zhu M; Wang Y; Chen M; Peng Z
Front Oncol; 2021; 11():751777. PubMed ID: 34745980
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma with non-B and non-C hepatitis origin: epidemiology in Japan and surgical outcome.
Kokudo N; Takemura N; Kanto T; Tateishi R; Igari T; Hasegawa K
Glob Health Med; 2019 Oct; 1(1):23-29. PubMed ID: 33330751
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis.
Gao Y; Wang PX; Cheng JW; Sun YF; Hu B; Guo W; Zhou KQ; Yin Y; Li YC; Wang J; Huang JF; Qiu SJ; Zhou J; Fan J; Yang XR
Cancer Med; 2019 Nov; 8(16):6933-6944. PubMed ID: 31566899
[TBL] [Abstract][Full Text] [Related]
9. Performance evaluation of TRUPCR
Lall S; Choudhary MC; Mahajan S; Kumar G; Gupta E
Virusdisease; 2019 Jun; 30(2):186-192. PubMed ID: 31179355
[TBL] [Abstract][Full Text] [Related]
10. HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma.
Ge Z; Tian T; Meng L; Song C; Yu C; Xu X; Liu J; Dai J; Hu Z
Cancer Med; 2019 Jun; 8(6):3086-3093. PubMed ID: 31033235
[TBL] [Abstract][Full Text] [Related]
11. Viral hepatitis and hepatocellular carcinoma: etiology and management.
Zamor PJ; deLemos AS; Russo MW
J Gastrointest Oncol; 2017 Apr; 8(2):229-242. PubMed ID: 28480063
[TBL] [Abstract][Full Text] [Related]
12. Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.
Liu X; He L; Han J; Wang L; Li M; Jiang Y; Wang X; Yang Z
PLoS One; 2017; 12(2):e0170605. PubMed ID: 28231294
[TBL] [Abstract][Full Text] [Related]
13. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.
Sarin SK; Kumar M; Lau GK; Abbas Z; Chan HL; Chen CJ; Chen DS; Chen HL; Chen PJ; Chien RN; Dokmeci AK; Gane E; Hou JL; Jafri W; Jia J; Kim JH; Lai CL; Lee HC; Lim SG; Liu CJ; Locarnini S; Al Mahtab M; Mohamed R; Omata M; Park J; Piratvisuth T; Sharma BC; Sollano J; Wang FS; Wei L; Yuen MF; Zheng SS; Kao JH
Hepatol Int; 2016 Jan; 10(1):1-98. PubMed ID: 26563120
[TBL] [Abstract][Full Text] [Related]
14. SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.
Zhang X; You Q; Zhang X; Chen X
Int J Mol Sci; 2015 Sep; 16(9):22662-75. PubMed ID: 26393582
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy.
Chen WC; Cheng JS; Chiang PH; Tsay FW; Chan HH; Chang HW; Yu HC; Tsai WL; Lai KH; Hsu PI
PLoS One; 2015; 10(6):e0131545. PubMed ID: 26121480
[TBL] [Abstract][Full Text] [Related]
16. Management of chronic hepatitis B in severe liver disease.
Fung J; Lai CL; Yuen MF
World J Gastroenterol; 2014 Nov; 20(43):16053-61. PubMed ID: 25473157
[TBL] [Abstract][Full Text] [Related]
17. Induction of apurinic endonuclease 1 overexpression by endoplasmic reticulum stress in hepatoma cells.
Cheng TL; Chen PS; Li RH; Yuan SS; Su IJ; Hung JH
Int J Mol Sci; 2014 Jul; 15(7):12442-57. PubMed ID: 25026174
[TBL] [Abstract][Full Text] [Related]
18. Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection.
Li C; Zhu WJ; Wen TF; Dai Y; Yan LN; Li B; Yang JY; Wang WT; Xu MQ
J Gastrointest Surg; 2014 Aug; 18(8):1469-76. PubMed ID: 24903846
[TBL] [Abstract][Full Text] [Related]
19. An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma.
Zhang X; Wang J; Cheng J; Ding S; Li M; Sun S; Zhang L; Liu S; Chen X; Zhuang H; Lu F
J Viral Hepat; 2014 Apr; 21(4):264-71. PubMed ID: 23941364
[TBL] [Abstract][Full Text] [Related]
20. Induction of Bcl-2 expression by hepatitis B virus pre-S2 mutant large surface protein resistance to 5-fluorouracil treatment in Huh-7 cells.
Hung JH; Teng YN; Wang LH; Su IJ; Wang CC; Huang W; Lee KH; Lu KY; Wang LH
PLoS One; 2011; 6(12):e28977. PubMed ID: 22216150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
